Stran Stock Quote STRN - Stock Price, News, Charts, Message Board, Trades

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Stran and Company Inc (STRN) Quote

Stran and Company Inc (STRN)

1.34

0.00

(0.00%)

Closed September 18 4:00PM

Delayed by 15 minutes

1.34

0.00

( 0.00% )

Pre Market: 8:00PM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

1.34

Bid

1.30

Ask

1.36

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

1.34

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

18,573,000

Dividend Yield

-

PE Ratio

600.00

Earnings Per Share (EPS)

-

Revenue

75.89M

Net Profit

35k

Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise.

Sector

Advertising Agencies

Industry

Advertising Agencies

Website

www.stran.com

Headquarters

Carson City, Nevada, USA

Founded

-

Stran & Company CEO to Participate in Virtual Fireside Chat with EF Hutton Analyst Edward Reilly, at 10:00 a.m. ET Today

Quincy, MA, April 20, 2023 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that...

Stran & Company Promotes David Browner to Chief Financial Officer

Quincy, MA, March 31, 2023 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that...

Stran & Company Achieves 48.5% Increase in Revenue for the 2022 Fiscal Year and Returns to Profitability for the Fourth Quarter of 2022

Achieves Record Revenue of $18.3 million and Net Income of $903,000 for the Fourth Quarter of 2022 Conference call to be held today at 10:00 AM ET QUINCY, Mass., March 30, 2023 (GLOBE...

Stran & Company Schedules Fiscal 2022 Year Financial Results and Business Update Conference Call

Quincy, MA, March 22, 2023 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that...

Stran & Company Signs Customer Contract with Multinational Direct Selling Beauty Products Company

Quincy, MA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that...

Stran & Company Signs Definitive Agreement to Acquire T R Miller Co., Inc.

T R Miller generated over $19 million of revenue in FY 2022 Further strengthens Stran’s presence in the industry Distribution and processing center expected to significantly expand Stran’s...

Stran & Company CEO Delivers 2022 Review to Shareholders

Quincy, MA, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that...

Stran & Company Completes Acquisition of Premier NYC

Quincy, MA, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that...

Stran & Company Announces Nasdaq Ticker Symbol Change from ‘STRN’ to ‘SWAG’ on December 16

Quincy, MA, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: STRN) (NASDAQ: STRNW), a leading outsourced marketing solutions provider that...

Stran & Company Signs Definitive Agreement to Acquire Premier NYC

Quincy, MA, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: STRN) (NASDAQ: STRNW), a leading outsourced marketing solutions provider that...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ZEOZeo Energy Corporation	$ 4.10 (259.65%)	3.04M
XCURExicure Inc	$ 6.39 (179.04%)	3M
TBIOTelesis Bio Inc	$ 3.29 (141.91%)	3.92M
VEROVenus Concept Inc	$ 0.82 (63.18%)	3.13M
FRGTFreight Technologies Inc	$ 0.178 (43.66%)	24.55M
BNRBurning Rock Biotech Ltd	$ 1.51 (-56.66%)	1
PGNYProgyny Inc	$ 17.90 (-26.76%)	63.27k
ATMCAlphaTime Acquisition Corporation	$ 9.00 (-19.64%)	10
CUTRCutera Inc	$ 0.64 (-16.05%)	13
VEEAVeea Inc	$ 10.32 (-15.76%)	36.88k
FRGTFreight Technologies Inc	$ 0.178 (43.66%)	24.55M
MAXNMaxeon Solar Technologies Ltd	$ 0.1078 (18.59%)	10.76M
VMARVision Marine Technologies Inc	$ 0.8647 (43.40%)	4.02M
TBIOTelesis Bio Inc	$ 3.29 (141.91%)	3.92M
VEROVenus Concept Inc	$ 0.82 (63.18%)	3.13M

starkd748

starkd748 4 minutes ago

Im a buyer if .0008s hold for another flip so far this trade has gone as exactly as I expected on the chart

TechandBio

TechandBio 7 minutes ago

$BTC Sound money digital gold should see 100-200k next year.
$SMMT went from $1.00-$25.00 better than Keytruda
ICCM icecure the founder of tencent owns over 50% of the shares kills many kinds of cancer by freezing it multiple studies some 5 years out undervalued.
https://www.pr

Smitty5150

Smitty5150 7 minutes ago

Also to your claim: You know nothing more than the next guy. Your right, in once sense. But in another would you argue that I am wrong in thinking the SP would fly with MHRA approval that coincided with NICE approval vs. just MHRA approval alone? I may not know "nothing more" but I do know what inv

Ms Labonte

Ms Labonte 9 minutes ago

I’m rolling $weet$$ got to $moke out em flipper$$$

jackson73

jackson73 10 minutes ago

TBIO 4.30 sweet

jackson73

jackson73 11 minutes ago

Bountiful_Harvest

Bountiful_Harvest 12 minutes ago

Inflation 2.0

https://pbs.twimg.com/media/GX0n3SOakAIJnBB?format=jpg&name=4096x4096

TechandBio

TechandBio 12 minutes ago

non invasive platforms in medical field doing amazing things PLSE ICCM

Princess17

Princess17 12 minutes ago

India took delivery of 47 mil oz

Smitty5150

Smitty5150 13 minutes ago

I have no idea who Fireman is, but my question still has not be answered with a definitive answer that is based on facts ( I dont like speculation) = Why hasn't NW started the evidence package for NICE? Why wasn't this being worked on well before the ASM? Linda Powers stated herself the work has be

Just the facts maam

Just the facts maam 13 minutes ago

Sr Convertible Notes may start getting converted when ANIP trades at or above $96.34 for 20 consecutive days after September 30, 2024. The following is from ANIP's filing.

Generally. Subject to ?Section 5.01(C)(ii), a Note may be Converted only in the following circumstances:

TrendTrade2016

TrendTrade2016 13 minutes ago

NOT MUCH FUN UNLESS YOU OWN IT...GREAT SHORT TRADE COMING UP

TechandBio

TechandBio 13 minutes ago

$SMMT was a dollar ICCM is .69 kills cancers across many indications including breast and lung cancers no side effects no IV no pills a platform that kills cancer by freezing it multiple studies done independently with 5 year data with 97% success rate 5 years out.
https://www.prnewswire.com/

jackson73

jackson73 14 minutes ago

GetSeriousOK

GetSeriousOK 17 minutes ago

An insider, or someone who did some DD.

Here it is straight from the horse's mouth: "The final rule will be issued in early November."
https://www.cms.gov/newsroom/fact-sheets/cy-2025-medicare-hospital-outpatient-prospective-payment-system-and-ambulatory-surgical-center

100lbStriper

100lbStriper 17 minutes ago

$NLST You can watch the Senate Judiciary Committee hearing today at 10 am ET through this link below. FYI, there is more on the agenda than the two IP bills.

https://www.judiciary.senate.gov/committee-activity/hearings/09/19/2024/executive-business-meeting-1

AGENDA

Invest-in-America

Invest-in-America 17 minutes ago

But, was HE paid?? And YOU were paid, naturally. Well then, GOD BLESS the both of you!!! (And we'll leave it at that.)

jackson73

jackson73 18 minutes ago

TBIO 3.50 ww room to go...

525k floater

Not likely

Not likely 20 minutes ago

And s/h's wanted out and it happened.

Pump a p/r then dump it.

This is static with this scam as everyone knows.

Old school playbook.

Lol with you pumpers always trying to deny the truth with this ruse.

Invest-in-America

Invest-in-America 21 minutes ago

And ZEO just landed on Jupiter, Homeboy!!! (BONKERS!!!)

davidsson10

davidsson10 23 minutes ago

Reasons To Choose Your Recipes Wisely

https://www.cnn.com/2024/09/18/health/mind-diet-cognitive-decline-wellness/index.html

Color, texture, flavor.....

exwannabe

exwannabe 25 minutes ago

Here is the path to biologic equivalence according to LP at the ASM [highlighting below is mine]. What part of no clinical trial is required don't you understand? Please explain where you get your claim that a clinical trial will be required to certify Eden for commercial production.
How do

retireat40

retireat40 25 minutes ago

The reaction so far hasn’t been overwhelming.

wagner

wagner 25 minutes ago

It would be great if intends will not be the only mentioned part of a new story,
still no volume and shortseller in charge.
Financing, loan could everything......

LTListener

LTListener 27 minutes ago

So many irons in the fire for sure.

Short-term (Q4) should be exciting as this is way overdue for an update on the OSA and NIH/gabakine platforms. The ampakine phase 2 SCI getting started is a big deal and I think investors would love to hear expected milestones on this trial and how

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions